Preventing Fractures in Patients with Osteoporosis or Low Bone Density: A Review of the Evidence- Osteoporosis is a skeletal disease which causes bone tissue loss, and is associated with disability, chronic pain, and an increased risk of bone fractures. In 2007, due to the increasing prevalence and costs associated with osteoporosis, the Agency for Healthcare Research and Quality (AHRQ) commissioned a systematic review of the literature on the comparative efficacy and harms of treatments for preventing osteoporotic fractures. Since the release of the original report, new formulations of bisphosphonates and a new biologic agent, denosumab, have become available in the US, prompting an update of the review.
Compare the efficacy and risks of various treatments to reduce the risk of osteoporotic fractures. Assess the effect of adherence on treatment efficacy.
Evaluate the harms related to therapies among specific patient subpopulations.
Establish the effects of bone mineral density monitoring and long-term use of antifracture treatment on outcomes.
1.0 Free CCMC CEUs for Case Managers
Expires 4/29/14
